Prudential Financial Inc Madrigal Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 5,913 shares of MDGL stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,913

Previous 5,130 15.26%

Holding current value

$3.04 Million

Previous $1.55 Million 74.74%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$287.52 - $458.66 $225,128 - $359,130	783 Added 15.26%	5,913 $2.71 Million
Q2 2025 Aug 12, 2025	BUY	$267.56 - $340.8 $121,204 - $154,382	453 Added 9.69%	5,130 $1.55 Million
Q1 2025 May 13, 2025	BUY	$272.79 - $355.88 $278,791 - $363,709	1,022 Added 27.96%	4,677 $1.55 Million
Q4 2024 Feb 11, 2025	BUY	$202.45 - $354.85 $461,990 - $809,767	2,282 Added 166.21%	3,655 $1.13 Million
Q3 2024 Nov 13, 2024	BUY	$212.22 - $292.96 $10,823 - $14,940	51 Added 3.86%	1,373 $291,000
Q2 2024 Aug 13, 2024	BUY	$193.33 - $291.99 $39,245 - $59,273	203 Added 18.14%	1,322 $370,000
Q1 2024 May 14, 2024	SELL	$171.37 - $283.23 $171 - $283	-1 Reduced 0.09%	1,119 $298,000
Q4 2023 Feb 13, 2024	BUY	$120.4 - $237.13 $134,848 - $265,585	1,120 New	1,120 $259,000
Q2 2023 Aug 11, 2023	SELL	$203.88 - $312.0 $1.02 Million - $1.56 Million	-5,008 Reduced 82.82%	1,039 $240,000
Q1 2023 May 12, 2023	SELL	$231.06 - $307.08 $1.63 Million - $2.16 Million	-7,047 Reduced 53.82%	6,047 $1.46 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $452,814 - $2.3 Million	-7,755 Reduced 37.2%	13,094 $0
Q3 2022 Nov 04, 2022	BUY	$60.57 - $79.51 $3,028 - $3,975	50 Added 0.24%	20,849 $1.36 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $574,886 - $992,481	9,905 Added 90.92%	20,799 $1.49 Million
Q2 2020 Aug 12, 2020	BUY	$60.13 - $125.71 $1,202 - $2,514	20 Added 0.18%	10,894 $1.23 Million
Q1 2020 May 12, 2020	SELL	$66.76 - $93.49 $5,073 - $7,105	-76 Reduced 0.69%	10,874 $725,000
Q4 2019 Feb 11, 2020	BUY	$84.28 - $118.5 $835,214 - $1.17 Million	9,910 Added 952.88%	10,950 $997,000
Q3 2018 Nov 07, 2018	BUY	$207.3 - $300.31 $43,533 - $63,065	210 Added 25.3%	1,040 $0
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $84,286 - $260,536	830 New	830 $0

Others Institutions Holding MDGL

# of Institutions

391

Shares Held

23.2M

Call Options Held

654K

Put Options Held

490K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $8.81B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Madrigal Pharmaceuticals, Inc. Transaction History